
Treatment of indolent primary cutaneous B-cell lymphomas with subcutaneous interferon-alfa
Keywords: follicle center lymphoma; interferon-alfa; marginal zone B-cell lymphoma; primary cutaneous B-cell lymphoma; systemic treatment; AE; adverse events; CR; complete remission; EORTC; European Organization for Research and Treatment of Cancer; PCBCL; primary